Last $29.72 USD
Change Today +0.60 / 2.06%
Volume 91.8K
GHDX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kimberly J. Popovits

Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee, Genomic Health Inc.
AgeTotal Calculated CompensationThis person is connected to 50 board members in 2 different organizations across 3 different industries.

See Board Relationships
55$2,140,184
As of Fiscal Year 2013

Background*

Ms. Kimberly J. Popovits, also known as Kim, has been the Chief Executive Officer and President of Genomic Health Inc. since January 2009 and February 2002 respectively. Ms. Popovits served as the Chief Operating Officer at Genomic Health Inc. from February 2002 to January 2009. She has over twenty years of Pharmaceutical and Biopharmaceutical experience. She served in various roles at Genentech, Inc., as Senior Vice President of Marketing and Sales from February 2001 ...

Read Full Background

Corporate Headquarters*

301 Penobscot Drive
Redwood City, California 94063

United States

Phone: 650-556-9300
Fax: --

Board Members Memberships*

Director
Former Director
2002-Present
Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
2005-N/A
Former Vice Chairman, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education*

BA
Michigan State University

Other Affiliations*

Annual Compensation*

Salary$600,000
Total Annual Compensation$600,000

Stock Options*

Restricted Stock Awards$324,360
Exercised Options32,500
Exercised Options Value$946,367
Exercisable Options354,679
Unexercisable Options145,834
Total Value of Options$946,367
Total Number of Options533,013

Total Compensation*

Total Annual Cash Compensation$925,800
Total Short Term Compensation$600,000
Other Long Term Compensation$324,360
Total Calculated Compensation$2,140,184
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GHDX:US $29.72 USD +0.60

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Howard B. Doran Jr.Chief Executive Officer, President and Director
LipoScience, Inc.
--
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
$384.2K
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
$380.0K
Michael J. Pellini M.D., MBAChief Executive Officer, President and Director
Foundation Medicine, Inc.
$403.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOMIC HEALTH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.